The Market for Stem Cell Research Products: Current and Future Opportunities
|出版日||ページ情報||英文 150 Pages
|幹細胞研究製品の市場：現在・将来の機会 The Market for Stem Cell Research Products: Current and Future Opportunities|
|出版日: 2012年11月15日||ページ情報: 英文 150 Pages||
The market for stem cell research products continues to flourish. As stem cell research begins to yield actionable therapies, companies are investing resources in this area of research that stands to revolutionize the way many diseases are treated. Pharmaceutical and biotech companies are seeking to leverage portfolios beleaguered by high drug attrition rates and expiring patents, and the use of stem cells in the drug discovery phase, rapid developments in regenerative medicine and the emergence of novel cellbased therapies promise to offer exciting new revenue streams. Increasingly, industry and academic institutions are collaborating on stem cell research and product development.
But given that practical stem-cell based therapies can take years to develop and are often stalled by heavy regulation, suppliers are in need of gaining a clear understanding of the wide range of products that support the stem cell research that is currently underway in both academic and industrial labs.
The Market for Stem Cell Research Products: Current and Future Opportunities, BioInformatics LLC's latest report, was designed to help suppliers assess how today's stem cell products market is driven by ongoing stem cell research requirements and how to best address the needs of the current market, to include a market size estimate (by expenditure) for stem cell products and lines worldwide. We surveyed 371 scientists from around the world about their current - and planned - areas of research, usage of stem cell products and preferred suppliers. This report will help decision-makers determine areas poised for growth (i.e., media, sera, supplements and cell lines) in the stem cell research products market, identify key competitors (including expenditure share for each major supplier), and plan a longterm strategy to secure a leading position in this expanding market. Combined with data on scientists' stem cell research budgets and predicted changes in spending through 2015, suppliers can use this information to anticipate areas of growth and product saturation.
This analysis also provides suppliers with critical insights into optimizing product offerings based upon scientists' use of and level of satisfaction with stem cell culture products. Additionally, the report reveals what channels stem cell scientists use to access information relevant to their research, which in turn can be used by suppliers to more effectively target their customer outreach.
To continue the exploration of the stem cell products market that began in BioInformatics LLC's 2009 report on the same topic, The Market for Stem Cell Research Products: Current and Future Opportunities will also contain trending data on a significant number of metrics. The 2012 report will highlight changes in the stem cell market now that the ban on federal funding for research on human embryonic stem cells has been lifted - and for the most part upheld by the courts - for over three years. By investing in this report, suppliers of stem cell products will be able to assess where the market has been, where it is now and where it is headed over the next few years.
The goal of this study is to provide life science suppliers selling products that support stem cell research with insights into the stem cell market to optimize product offerings that best meets researchers' needs:
Stem Cell Features Studied
Stage of Stem Cell Workflow Majority of Time is Spent
The Market for Stem Cell Research Products: Current and Future Opportunities is based on responses to a 50-question online survey conducted by BioInformatics, LLC. The questionnaire was completed by 371 life scientists worldwide who currently perform stem cell research between October 1 and 18, 2012.
The electronic questionnaire was fielded to registered members of The Science Advisory Board®. BioInformatics sponsors The Science Advisory Board, an online community of almost 70,000 scientists, physicians and healthcare professionals from around the world. The Science Advisory Board is divided into two panels (Research and Clinical) and “convenes” regularly via the World Wide Web to voice their opinions on a wide variety of issues relating to biomedical research and clinical technologies. These experts - representing all aspects of the life sciences and medicine - have agreed to make themselves available to participate in our online research activities. The Science Advisory Board members who participated in this study were drawn from the Board's Research Panel.